What is Pediatrix Medical Group's market cap?

Pediatrix Medical Group (MD) has a market capitalization of $2.1B and trades on NYSE.

What is Pediatrix Medical Group's revenue and profitability?

Pediatrix Medical Group generated $1.9B in trailing twelve-month revenue with net income of $174.2M, representing a net margin of 9.0%, with free cash flow of $237.3M. These figures are based on the Q1 2026 filing.

Who are Pediatrix Medical Group's competitors?

Pediatrix Medical Group's key competitors include Ardent Health, Inc., InfuSystem Holdings, Inc., Utah Medical Products Inc, and others. These companies compete in similar markets and product categories.

Who does Pediatrix Medical Group partner with?

Pediatrix Medical Group's notable partners include Nextgen Healthcare, pMD.

What subsidiaries does Pediatrix Medical Group have?

Pediatrix Medical Group's subsidiaries include Pediatrix Medical Group of Florida.

Where is Pediatrix Medical Group headquartered?

Pediatrix Medical Group is headquartered in United States of America and employs approximately 2,900 people. It has been publicly traded since 1959.

Pediatrix Medical Group

Pediatrix Medical Group is a leading provider of specialized physician services focused on newborn, maternal-fetal, and pediatric subspecialty care across the United States.

Market cap

$2.15B+102%

Revenue$1.9B-2.3%

Net income$174.2M+260%

Free cash flow$237.3M+22.1%

EPS (diluted)$2.06+256%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 5, 2026

Revenue$476.2MBeat by $10.4M EPS$0.44Beat by $0.07

Read the full report

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$478.5M

EPS estimate$0.57

Financials

Q1 2026

Income statement

See full

Revenue$476.2M+3.9%

Operating income$41.7M+29.8%

Net income$29.6M+42.6%

EPS (diluted)$0.36+50.0%

Balance sheet

See full

Cash & equivalents$205.8M+108%

Total debt$629.7M-3.9%

Total equity$878.6M+11.3%

Total assets$2.1B+3.9%

Cash flow

See full

Operating cash flow-$129.8M-10.5%

CapEx$6.2M+88.3%

Free cash flow-$136.1M-12.7%

Valuation & ratios

Valuation

See full

Market cap$2.15B+102%

Enterprise value$2.57B+69.9%

P/E12.3×—

P/S1.1×+0.5×

Profitability

See full

Operating margin11.3%—

Net margin9%—

FCF margin12.3%+2.5pp

Returns & leverage

See full

Return on equity20.9%—

Debt / equity0.7×-0.1×

Current ratio1.3×-0.5×

Segments

By product

See full

Health Care Patient Service$405.4M+4.1%

Hospitals Contracts$69.9M+7.3%

Competitors

By market cap

HCA Healthcare$86.4B+5.5%

GE HealthCare Technologies$27.8B-21.9%

Tenet Healthcare$21.0B+44.2%

Pediatrix Medical Group$2.1B+97.2%

ARD

Ardent Health Partners$1.6B+2.9%

Nutex Health Inc.$1.0B+99.4%

Utah Medical Products$220.0M+18.4%

InfuSystem Holdings$188.9M+52.6%

By revenue growth

Nutex Health Inc.+40.9%

HCA Healthcare+7.3%

ARD

Ardent Health Partners+6.7%

GE HealthCare Technologies+6.5%

Tenet Healthcare+5.4%

InfuSystem Holdings+3.5%

Pediatrix Medical Group-2.3%

Utah Medical Products-7.0%

By net margin

Utah Medical Products29.04%-3.3pp

Tenet Healthcare13.55%+2.0pp

Nutex Health Inc.10.95%-0.9pp

GE HealthCare Technologies9.33%-1.9pp

Pediatrix Medical Group9.02%+14.5pp

HCA Healthcare8.77%+0.6pp

InfuSystem Holdings5.56%+3.2pp

ARD

Ardent Health Partners2.09%-1.6pp

Profile

Pediatrix Medical Group is a leading provider of specialized physician services focused on newborn, maternal-fetal, and pediatric subspecialty care across the United States. The company operates a national network of affiliated physicians who provide clinical care primarily within hospital-based neonatal intensive care units (NICUs) and specialized maternal-fetal practices. Its core value proposition centers on improving clinical outcomes for high-risk expectant mothers and premature infants through evidence-based medicine and integrated physician practice management.

Competitive position

Pediatrix is a leading national provider of neonatal and maternal-fetal physician services, maintaining a significant presence in hospital-based NICUs across 37 states.

GeographiesUnited States

Customer segmentsHospitals, Government healthcare programs, Commercial health insurers

Business modelProfessional services, Management services organization (MSO), Fee-for-service

SuppliersMedical schools and residency programs, Medical equipment manufacturers, Pharmaceutical companies, Information technology and EHR vendors

CustomersHospitals and health systems, Commercial insurance payors, State Medicaid programs, Self-pay patients

CountryUnited States of America

Listed1959

Employees2.9K

CEOMark S. Ordan

SectorHealthcare

IndustryMedical - Care Facilities

Websitepediatrix.com

FilingsSEC EDGAR

Ask your AI about Pediatrix Medical Group.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pediatrix Medical Group's market cap?: Pediatrix Medical Group (MD) has a market capitalization of $2.1B and trades on NYSE.
What is Pediatrix Medical Group's revenue and profitability?: Pediatrix Medical Group generated $1.9B in trailing twelve-month revenue with net income of $174.2M, representing a net margin of 9.0%, with free cash flow of $237.3M. These figures are based on the Q1 2026 filing.
Who are Pediatrix Medical Group's competitors?: Pediatrix Medical Group's key competitors include Ardent Health, Inc., InfuSystem Holdings, Inc., Utah Medical Products Inc, and others. These companies compete in similar markets and product categories.
Who does Pediatrix Medical Group partner with?: Pediatrix Medical Group's notable partners include Nextgen Healthcare, pMD.
What subsidiaries does Pediatrix Medical Group have?: Pediatrix Medical Group's subsidiaries include Pediatrix Medical Group of Florida.
Where is Pediatrix Medical Group headquartered?: Pediatrix Medical Group is headquartered in United States of America and employs approximately 2,900 people. It has been publicly traded since 1959.